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Pseudomonas aeruginosa has developed diverse strategies to respond and adapt to
antibiotic stress. Among the factors that modulate survival in the presence of antibiotics,
alternative sigma factors play an important role. Here, we demonstrate that the
alternative sigma factor RpoN (σ54) promotes survival in the presence of tobramycin. The
tobramycin-sensitive phenotype of logarithmic phase 1rpoN mutant cells is suppressed
by the loss of the alternative sigma factor RpoS. Transcriptional analysis indicated
that RpoN positively regulates the expression of RsmA, an RNA-binding protein, in
the P. aeruginosa stationary growth phase in a nutrient-rich medium. The loss of
RpoS led to the upregulation of gacA expression in the nutrient-limited medium-grown
stationary phase cells. Conversely, in the logarithmic growth phase, the 1rpoS mutant
demonstrated lower expression of gacA, underscoring a regulatory role of RpoS for
GacA. Supplementation of tobramycin to stationary phase 1rpoN mutant cells grown in
nutrient-rich medium resulted in decreased expression of gacA, relA, and rpoS without
altering the expression of rsmA relative to wild-type PAO1. The observed downregulation
of gacA and relA in the 1rpoN mutant in the presence of tobramycin could be reversed
through the mutation of rpoS in the 1rpoNmutant background. The tobramycin-tolerant
phenotype of the 1rpoN1rpoS mutant logarithmic phase cells may be associated with
the expression of relA, which remained unresponsive upon addition of tobramycin.
The logarithmic phase 1rpoS and 1rpoN1rpoS mutant cells demonstrated increased
expression of gacA in response to tobramycin. Together, these results suggest that a
complex regulatory interaction between RpoN, RpoS, the Gac/Rsm pathway, and RelA
modulates the P. aeruginosa response to tobramycin.
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INTRODUCTION
Pseudomonas aeruginosa is a Gram-negative pathogen that possesses an extremely high capacity to
survive in different environmental niches and poses serious medical risk to immunocompromised
patients and patients with cystic fibrosis (CF) (Rau et al., 2010; Silby et al., 2011). One of the major
problems is the high resistance of P. aeruginosa to a wide range of antibiotics (Lister et al., 2009;
Poole, 2011). To overcome the effect of antimicrobials without the expression of a specific resistance
mechanism, P. aeruginosa employs a strategy known as antibiotic tolerance. This phenomenon
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allows the adaptation to antibiotic stress through the production
of antibiotic-tolerant persister cells. These cells demonstrate the
capacity to withstand the effects of elevated antibiotic levels
and the ability to persist (Lewis, 2008, 2012). The presence of
antibiotic-tolerant cells is the major cause of recurrent infections
(Fauvart et al., 2011). Therefore, greater understanding of the
molecular mechanism underlying antibiotic tolerance could lead
to the development of strategies to prevent recurrent infections
caused by P. aeruginosa.
The stationary growth phase of P. aeruginosa, which produces
a substantial amount of cells tolerant to antibiotics (Keren
et al., 2004), is characterized by the production of different
virulence factors governed by the activation of quorum sensing
(QS) systems, which are organized in a hierarchical cascade
with the las system controlling the expression of the rhl system
and the Pseudomonas quinolone system (PQS) serving as a
link between the las and rhl QS systems (Pesci et al., 1997;
McKnight et al., 2000). Activation of the QS system and
the corresponding production of virulence factors affects the
response of P. aeruginosa to antimicrobials (Möker et al., 2010;
Que et al., 2013). A number of genes of P. aeruginosa including
relA, spoT, dksA, the alternative sigma factors, RpoS and RpoN,
and the signaling molecule PQS, promote the production of
antibiotic-tolerant populations (Murakami et al., 2005; Viducic
et al., 2006, 2007; Häussler and Becker, 2008; Kayama et al., 2009;
Nguyen et al., 2011).
Sigma factors are indispensable for the control of transcription
and the regulation of a wide range of genes implicated in diverse
functions within the cells, making them important targets for
interactions with antimicrobial agents (Kazmierczak et al., 2005).
The alternative sigma factor RpoS (σ s) is the master regulator
of the stationary phase and is involved in the regulation of
QS; the QS system positively controls the expression of RpoS
(Fujita et al., 1994; Whiteley et al., 2000; Schuster et al., 2004).
Another alternative sigma factor, RpoN (σ 54), is involved in the
regulation of nitrogen, motility, mucoidy, and QS (Totten et al.,
1990; Heurlier et al., 2003; Thompson et al., 2003; Damron et al.,
2012; Sana et al., 2013). Furthermore, we have recently reported
that RpoN employs PQS and PqsE to overcome the action of
carbapenems (Viducic et al., 2016).
In P. aeruginosa, given the roles of RpoN in the regulation
of major metabolic pathways, the regulatory control of the
translational apparatus, and antibiotic tolerance (Totten et al.,
1990; Schulz et al., 2015; Viducic et al., 2016), it is of
interest to further our understanding of the mechanism of
the RpoN-dependent network in response to aminoglycosides,
such as tobramycin. Tolerance to tobramycin has been mainly
addressed in context of biofilm-formed cells (Whiteley et al.,
2001; Bjarnsholt et al., 2005) however, the key mediators of
the response to tobramycin in planktonic cells have not been
elucidated. Tobramycin is commonly used in the treatment
of P. aeruginosa respiratory infections in patients with CF
(Ratjen et al., 2009). To kill bacteria, aminoglycosides must bind
to the 30S ribosomal subunit and interfere with translation.
Furthermore, aminoglycosides induce the insertion of misread
proteins into the bacterial cell membrane, affecting membrane
integrity and leading to cell death (Davis, 1987; Kohanski et al.,
2008). Aminoglycosides can kill both growing and non-growing
cells, making them very useful in the treatment of chronic
infections (Spoering and Lewis, 2001).
It has long been established that metabolic stress conditions
trigger the production of ppGpp, an alarmone of the stringent
response that controls a cellular switch leading to translational
arrest, modulation of gene expression for the promotion of cell
survival, and is an essential trigger of antibiotic tolerance (Cashel
et al., 1996; Potrykus and Cashel, 2008; Amato et al., 2014).
Because mutation of rpoN affects expression of the sigma factor
RpoS, which is implicated in the antimicrobial stress response,
and is positively regulated by ppGpp (Murakami et al., 2005;
Kayama et al., 2009; Battesti et al., 2011), and the existence of
σ
54-dependent activation of relA in nitrogen-starved cells (Brown
et al., 2014), we have chosen to investigate how the interaction of
RpoN with RpoS modulates the response to tobramycin.
Our data demonstrate that RpoN predominantly facilitates
the survival to tobramycin in nutrient-rich and nutrient-
limited media. The inactivation of rpoS in the 1rpoN
mutant background in the logarithmic growth phase eliminates
the tobramycin-sensitive phenotype of the 1rpoN mutant,
suggesting that the RpoS-dependent pathway has an important
role in defining the response to tobramycin through the activity
of relA as well as consequent ppGpp production. Transcriptional
analyses demonstrated that in response to tobramycin, the
1rpoN mutant differentially regulates the expression of the gacA,
rsmA, relA, and rpoS genes.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
The bacterial strains, plasmids, and primers used and generated
in this study are shown in Table 1. Bacteria were routinely
cultured at 37◦C in Luria Bertani medium (LB), AB medium
supplemented with 0.2% glucose, 0.2% casamino acids (CAA)
(Clark and Maaløe, 1967) and 1 mM L-glutamine for growth
of the 1rpoN mutant, or on LB-agar plates supplemented with
10% sucrose when necessary. Vogel-Bonner minimal medium
(VBMM) (Vogel and Bonner, 1956) was used in mating
experiments. Antibiotics for plasmid selection and propagation
were added as required: gentamicin (20 µg/ml) and ampicillin
(100 µg/ml) (for E. coli), and gentamicin (100 µg/ml) and
carbenicillin (400 µg/ml) (for P. aeruginosa)
Reagents
Tobramycin was purchased from Sigma-Aldrich (St. Louis, MO),
and was used at a concentration of 32 µg/ml.
Antibiotic Susceptibility Testing
The minimum inhibitory concentration (MIC) of tobramycin
was determined using the broth microdilution method as
previously described (Miyake et al., 1992; Viducic et al., 2016),
with the following modifications: bacterial suspensions were
incubated in LB medium at a density of 106 CFU/ml. MICs
were determined after 24 h of incubation at 37◦C. The MIC was
defined as the lowest concentration of antimicrobial agent that
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TABLE 1 | Bacterial strains, plasmids, and oligonucleotides used in the study.
E. coli
DH5α F−endA1 hsdR17 supE44 thi-1 recA1 TakaRa
gyrA96 relA1 1(lacZYA-argF ) U169
deoR λ(ϕ80dlacZ1M15)
S17-1 λpir pro thi hsdR+ Tpr Smr; chromosome::RP4-2 Tc::Mu-Kan::Tn7/λpir Simon et al., 1983
P. aeruginosa
PAO1 Wild-type Stover et al., 2000
PAO1 1rpoN PAO1 in-frame deletion of rpoN Viducic et al., 2016
PAO1 1rpoN1rpoS PAO1 in-frame deletion of rpoN and rpoS This study
PAO1 1rpoS PAO1 in-frame deletion of rpoS Viducic et al., 2017
PAO1 1rpoN/rpoN+ 1rpoN mutant carrying a wild-type copy of rpoN on pMMB67EH This study
Plasmids
pEX18Gm Broad-host-range gene replacement vector; sacB, Gmr Hoang et al., 1998
pEX18Gm-1rpoN rpoN deletion suicide vector Viducic et al., 2016
pEX18Gm-1rpoS rpoS deletion suicide vector Viducic et al., 2017
pMMB67EH IncQ broad-host-range cloning vector, Apr Fürste et al., 1986
pMMB67EH-rpoN pMMB67EH containing a functional rpoN gene in the opposite orientation to the tac promoter, Apr This study
Primers for mutant construction and complementation:
rpoN-up-F ATAGAATTCCGATCTCGGTCGGCGACATC Viducic et al., 2016
rpoN-up-R ATAGGATCCCTGGAGGTCCAGGGTGGATAG Viducic et al., 2016
rpoN-down-F ATAGGATCCGGCATAGCCCCTTCGAGCGAG Viducic et al., 2016
rpoN-down-R ATAAAGCTTCTCCGGCAGCTCCCTGGCTA Viducic et al., 2016
rpoS-up-F CATTCAGGTCGGTCAAGCTATCCA Viducic et al., 2017
rpoS-up-R TCCGTCACTGTGCCATGTCGTTATCCCTTG Viducic et al., 2017
rpoS-down-F CGACATGGCACAGTGACGGAAAACCTTAGA Viducic et al., 2017
rpoS-down-R GGAAGTCTGGCCGAACATCACGA Viducic et al., 2017
rpoN-HindIII-F CCCAAGCTTGGGAAGTCTACCTGGGGCACGAGT This study
rpoN-EcoRI-R CCGGAATTCCGGTCCTTGTTGCCCGTGTGTAAGT This study
Primers for qRT-PCR:
rsmA-F TGGGTGTCAAAGGGAACCA This study
rsmA-R TGGTAAATTTCCTCCCGGTGTA This study
relA-F CCCCAAGGAAAACGGCTATC This study
relA-R TGGAGTGGGTACGGATCTGTACT This study
rpoS-F CACTTCCTTCTCTCCAAACAACA Viducic et al., 2016
rpoS-R AGCTGCGTTGCGTCCAA Viducic et al., 2016
omlA-F CGAACTATCAACCAGCTGGTG Viducic et al., 2016
omlA-R GCTGTGCTCTTGCAGGTTGTG Viducic et al., 2016
aTpr , Smr , Apr , and Gmr , resistance to trimethoprim, streptomycin, ampicillin, and gentamicin, respectively. Introduced restriction sites are underlined, and the sequences introduced
for overlap extension PCR are in italics.
completely inhibited the growth of the organism, as detected by
the unaided eye.
Time-Kill Assays
For the time-kill studies, approximately 108 CFU/ml stationary
phase cells were challenged after 16 h of cultivation. Cells were
washed once, resuspended in fresh LB or AB medium and then
grown with antibiotic in a shaker at 37◦C for 24 h. For the
logarithmic phase time-kill assay, the cells from overnight culture
were diluted in the medium and grown to an OD595 of 0.3; at
this point, the antibiotic was added, and the experiment was
continued for 3 h at 37◦C. Samples were collected at several time
points, 10-fold serial dilutions were prepared with 0.85% NaCl
and 100 µl samples were plated onto LB or AB agar plates in
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duplicate. Microbial killing was assessed at defined time points
by counting colonies and calculating the percent survival relative
to untreated cells at time zero. Data were collected from at least
three independent experiments. Each experiment included one
growth control without addition of tobramycin.
Generation of Mutant Strains
Unmarked deletions of rpoN and rpoS were constructed in P.
aeruginosa PAO1 (Stover et al., 2000) as described previously
(Viducic et al., 2016, 2017) using the pEX18Gm suicide vector,
which uses the sacB-based counterselection method (Schweizer,
1992; Hoang et al., 1998). A single deletion was first constructed
in rpoN, which was then used to generate the 1rpoN1rpoS
mutant. The plasmids were transformed into E. coli S17-1 λpir
(Simon et al., 1983) and conjugated into P. aeruginosa PAO1 to
generate an in-frame deletion of the genes. The transconjugants
carrying the integrated plasmid on the chromosome were
selected on LB-agar plates containing 10% (wt/vol) sucrose,
and sucrose resistant colonies were screened using colony PCR
to identify mutants. The deletion was confirmed by PCR and
sequencing.
For complementation studies, a 2.5-kb HindIII-EcoRI
fragment encompassing the rpoN gene was amplified by PCR,
digested with HindIII and EcoRI, and the generated fragment
was subsequently ligated into EcoRI-HindIII-digested broad-host
range vector pMMB67EH (Fürste et al., 1986). In this construct,
the rpoN gene conserved its own promoter and Shine-Dalgarno
sequence and was inserted in the opposite orientation with
respect to the tac promoter. This construct was conjugated in the
1rpoN mutant.
RNA Isolation and Quantitative Real-Time
PCR (qRT-PCR) Analysis
For stationary phase RNA isolation, the strains were grown
overnight in 10 ml of LB or AB medium at 37◦C for 16 h, and
then the cultures were washed and resuspended in 10 ml of LB or
ABmedium. RNAwas isolated at a time point before the addition
of tobramycin and at 24 h following the growth in the presence of
tobramycin. For RNA isolation from the logarithmic phase cells,
overnight cultures were used to inoculate 10-ml subcultures in
LB to an OD595 of 0.01. Cultures were incubated at 37
◦C to an
OD595 of 0.3; at this point a sample was taken for RNA isolation.
Then, tobramycin was added to the culture, and cultures were
incubated for an additional 3 h; cells were then harvested for
RNA isolation. Total RNA was isolated from P. aeruginosa using
RNeasy Miniprep Kit according to the manufacturer’s protocol
(Qiagen). Total RNA was on column DNase- treated using
RQ1 DNase (Promega) and was used as a template in PCR to
assess the presence of contaminating DNA. cDNA was generated
from 1 µg of DNase-treated RNA using the Transcriptor First
Strand cDNA Synthesis Kit (Roche Diagnostics) according to
the manufacturer’s instructions. qRT-PCR reactions were carried
out in a StepOnePlus Real-Time PCR Systems (Thermo Fisher
Scientific) using the Fast SYBR R© Green Master Mix (Thermo
Fisher Scientific), according to the specification of the supplier.
To correct for the differences in the amount of starting material,
a constitutively expressed omlA was used as a reference gene
(Ochsner et al., 1999). The oligonucleotide primers used to detect
the expression of each gene of interest are listed in Table 1. At
least three technical replicates were performed for each cDNA
sample analyzed.
Growth Assay
To assess the growth of the wild-type PAO1, the 1rpoN, 1rpoS,
1rpoN1rpoS, and 1rpoN/rpoN+ mutants, overnight grown
cultures were washed and used to inoculate 10-ml subcultures in
LB medium or AB medium to an OD595 of 0.01. The absorbance
at 595 nm was monitored every 2 h for 12 h, with an additional
measurement at 24 h.
Statistical Analysis
The data were statistically analyzed using Student’s t-test (two-
tailed two-sample assuming equal variances) using GraphPad
Prism7 software. Definition of statistical significance is P < 0.05.
RESULTS
1rpoN Mutants Are Sensitive to
Tobramycin Exposure
The capacity of P. aeruginosa to persist in the presence of
antimicrobial agents without acquiring resistance mechanisms
is attributed to the production of specialized antibiotic-tolerant
cells (Keren et al., 2004). One of the characteristics of antibiotic-
tolerant cells is that their mechanism of survival usually does
not reflect MIC values, which remain unchanged, and allows
them to grow in the presence of a high antibiotic concentration
(Brauner et al., 2016). To address whether the deletion of
rpoN and loss of rpoS in the 1rpoN mutant background
affects the MIC values of tobramycin, MIC determinations
were performed. The MIC values of tobramycin for wild-type
PAO1 and the 1rpoN, 1rpoS, and 1rpoN1rpoS mutants were
1 µg/ml.
The role of RpoN in conferring carbapenem and
fluoroquinolone tolerance (Viducic et al., 2007) prompted
us to investigate a potential role of RpoN in the interaction
with another class of antibiotics, such as aminoglycosides,
which target the translational machinery. To address this
question, we performed killing assays for stationary phase
wild-type PAO1 and the 1rpoN mutant grown in the LB
medium in the presence of tobramycin at 32 µg/ml, which
is a concentration corresponding to 32 × the MIC. The
1rpoN mutant stationary phase cells exhibited a significant
decrease in viability compared to wild-type PAO1, suggesting
that in the stationary phase, RpoN promotes survival in the
presence of tobramycin (Figure 1A). To confirm that the
tobramycin-sensitive phenotype was due to the loss of rpoN, we
complemented the 1rpoN mutant by introduction of plasmid
pMMB-rpoN, encoding a wild-type copy of rpoN gene. The
complemented strain, 1rpoN/rpoN+, demonstrated a wild-type
response to tobramycin, suggesting that the tobramycin-sensitive
phenotype was due to the loss of rpoN and not due to a secondary
mutation.
Previous studies on RpoN have suggested that QS systems
and RpoS are negatively regulated by RpoN (Heurlier et al.,
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FIGURE 1 | Time-dependent killing assay of stationary-phase (A) and logarithmic phase (B) wild-type PAO1 and the 1rpoN, 1rpoS, 1rpoN1rpoS, and
1rpoN/rpoN+ mutants treated with 32 µg/ml tobramycin grown in LB. Wild-type PAO1 was grown without tobramycin and served as a growth control. Percent
survival at the indicated time points was calculated by dividing the number of CFU/ml after antibiotic treatment by the CFU/ml before addition of tobramycin. The
experiment was performed in triplicate. Error bars indicate SDs. P ≤ 0.05 (*), ≤0.01 (**), or ≤0.001(***) vs. wild type.
2003; Kayama et al., 2009; Viducic et al., 2016). Given the
protective role of RpoS in the presence of aminoglycosides
(Baharoglu et al., 2013; Wang et al., 2014), we sought to
determine whether the response to tobramycin in the 1rpoN
mutant could be modulated through RpoS. To assess the role
of RpoS in tolerance to tobramycin, we constructed 1rpoS
and 1rpoN1rpoS mutants and performed a killing assay for
stationary phase cells in the presence of tobramycin at 32 µg/ml.
The level of survival of the 1rpoS mutant in the presence
of tobramycin was comparable to that observed for wild-type
PAO1. The survival rate of the 1rpoN1rpoS mutant resembled
that observed for the 1rpoN mutant; however, at the 24-h
time-point, the 1rpoN1rpoS mutant showed an increase in
survival relative to the 1rpoN mutant, partially overcoming the
RpoN-dependent response to tobramycin (Figure 1A). Having
confirmed the role of RpoN in response to tobramycin in
stationary phase cells, it was of interest to assess how inactivation
of rpoN affects the response to tobramycin in logarithmic
phase cells. To explore this, the cells were grown to an
OD595 of 0.3 and treated with tobramycin at 32 µg/ml. As
demonstrated in Figure 1B, the 1rpoN mutant demonstrated
a stark decrease in viability following exposure to tobramycin.
These results confirmed that irrespective of the growth phase,
the response to tobramycin is RpoN-dependent. In contrast, the
1rpoS mutant demonstrated insignificantly higher survival in
comparison to wild-type PAO1 (Figure 1B). The 1rpoN1rpoS
mutant completely abolished the effect of tobramycin from the
1-h time-point throughout the remainder of the experimental
timeframe and demonstrated increased survival relative to that
of wild-type PAO1 (Figure 1B). Furthermore, when the 1rpoN
mutant was complemented with the wild-type copy of rpoN, the
survival rate to tobramycin resembled that of wild-type PAO1
(Figure 1B).
Metabolic flexibility and rapid adaptation of P. aeruginosa
to diverse nutrient-limited conditions often correlates with a
decrease in susceptibility to antibiotics (Poole, 2012). Given
that RpoN has been implicated in the acquisition of nitrogen
and amino acid metabolism (Totten et al., 1990) and that
the stress response in P. aeruginosa is attributed to RpoS
(Suh et al., 1999), we decided to focus subsequent work on
investigating tobramycin tolerance by modulating the metabolic
status of the cells. To define the importance of nutrient-
limited conditions in tobramycin tolerance, we performed killing
assays with stationary phase cells in a defined minimal (AB)
medium supplemented with 0.2% glucose and 0.2% CAA. The
results of the killing assays demonstrated an overall increase in
survival to tobramycin in all strains; however, nutrient-limited
conditions failed to restore wild-type tolerance in the 1rpoN
mutant. The complemented 1rpoN mutant produced wild-type
survival in the presence of tobramycin (Figure 2A). Growth in
AB minimal medium failed to abolish the tobramycin-sensitive
phenotype of the logarithmic phase 1rpoN mutant cells, and
the logarithmic phase 1rpoS and 1rpoN1rpoS mutant cells
demonstrated a rapid decrease in survival after 1 h of treatment
with tobramycin, which was followed by a delay in killing
up to the 3-h time-point. The complemented 1rpoN mutant
demonstrated wild-type survival in response to tobramycin
(Figure 2B).
Growth rate analysis of the mutants in LB medium
indicated that the 1rpoN mutant grew slightly slower than
the wild-type PAO1, whereas the 1rpoN1rpoS mutant
displayed a more pronounced growth defect (Figure 3A).
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FIGURE 2 | Time-dependent killing assay of stationary-phase (A) and logarithmic phase (B) wild-type PAO1 and the 1rpoN, 1rpoS, 1rpoN1rpoS, and
1rpoN/rpoN+ mutants treated with 32 µg/ml tobramycin grown in a defined minimal (AB) medium supplemented with 0.2% glucose and 0.2% CAA. Wild-type PAO1
was grown without tobramycin and served as a growth control. Percentage survival at the indicated time points was calculated by dividing the number of CFU/ml after
antibiotic treatment by the CFU/ml before addition of tobramycin. The experiment was performed in triplicate. Error bars indicate SDs. P ≤ 0.05 (*), ≤0.01 (**) vs. wild
type.
FIGURE 3 | Growth rate analysis for wild-type PAO1, 1rpoN mutant, 1rpoS mutant, 1rpoN1rpoS mutant, and 1rpoN/rpoN+ mutant grown in the LB
medium (A) and AB minimal medium supplemented with 0.2% glucose and 0.2% CAA (B) at 37◦C. Growth curves showing the absorbance at 595 nm plotted over
time. Error bars indicate SDs. P ≤ 0.05 (*), ≤0.01 (**), or ≤0.001(***) vs. wild type.
Growth in the defined AB minimal medium resulted in
significantly delayed growth for the 1rpoN1rpoS mutant
and to a lesser extent for the 1rpoN and 1rpoS mutants
(Figure 3B). The complemented strain, 1rpoN/rpoN+,
restored the growth defect of the 1rpoN mutant
(Figures 3A,B).
Taken together, these data support the following key
findings: (i) RpoN is important for P. aeruginosa interaction
with tobramycin during both the stationary and logarithmic
growth phases; (ii) the logarithmic phase response of RpoN
to tobramycin is mediated through a mechanism that involves
RpoS; and (iii) the observed slow growth correlates with
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the 1rpoN1rpoS mutant being recalcitrant to killing by
tobramycin.
Tobramycin Differentially Affects the
Expression of gacA, rsmA, relA, and rpoS
Depending on the Metabolic Status of the
Cells
Based on our time-kill assays, which suggested the interaction
of RpoN with tobramycin via RpoS, we further focused our
attention on a search for genes that might interfere with
the mechanism of action related to aminoglycosides and
define the pathway for tobramycin tolerance in the 1rpoN
mutant. To modulate external signals into an adaptive response,
P. aeruginosa employs two-component systems consisting of a
sensor kinase that responds to specific signals by modifying the
phosphorylated state of a cognate response regulator (Gao et al.,
2007; Goodman et al., 2009). Post-transcriptional regulation
is one of the mechanisms used by bacteria to adapt to
environmental conditions and is regulated by RNA binding
proteins that control the translation of target mRNAs (Romeo
et al., 2013). GacS/GacA, a two-component system, controls
the expression of small trans-acting regulatory RNAs, RsmY,
and RsmZ, which interact with RsmA, an RNA-binding protein.
RsmA/CsrA binds to multiple sites of the 5′-untranslated region
(5′-UTR) close to the Shine-Dalgarno sequence, preventing
ribosomal binding, which mediates the post-transcriptional
control of genes involved in a number of physiological pathways
(Baker et al., 2002; Burrowes et al., 2006; Brencic et al., 2009;
Romeo et al., 2013). Taking into account that aminoglycosides act
by impairing the integrity of the inner cell membrane through
the incorporation of misread proteins, that they must bind the
30S ribosome subunit to interfere with translation to kill bacteria
(Davis, 1987; Kohanski et al., 2008) and that RsmA is one of
the targets for ribosome interaction and competes with the 30S
ribosomal subunit (Baker et al., 2002), we anticipated that the
Gac/Rsm pathway might be important for the tobramycin-stress
response.
To determine if tobramycin induces changes in the expression
of genes in the Gac/Rsm pathway, we investigated the expression
of gacA and rsmA in wild-type PAO1 and the mutant strains
grown to stationary phase in LB and AB media. For all
transcriptional analyses using qRT-PCR, we used the samples
from the 0 and 24-h time-point of the killing assays. In LB
medium, the most prominent difference was observed in the
1rpoN1rpoSmutant with a 2.2-fold decrease in gacA expression
relative to wild-type PAO1 (Figure 4A). Whereas gacA levels
in the 1rpoN and 1rpoS mutants remained unaltered after
tobramycin exposure, the 1rpoN mutant still demonstrated
a 2.4-fold lower expression relative to wild-type PAO1. The
1rpoN1rpoSmutant and wild-type PAO1 produced a significant
3.2- and 1.7-fold increase in gacA levels after tobramycin
exposure, respectively (Figure 4A). The expression of gacA in
AB medium in the 1rpoN and 1rpoN1rpoS mutants was
comparable to wild-type levels; however, the 1rpoS mutant
demonstrated significantly higher levels of gacA than wild-
type PAO1 (Figure 4B). The addition of tobramycin induced a
positive effect on expression of gacA in wild-type PAO1 and the
1rpoN1rpoS mutant, resulting in 2.2- and 1.7-fold increases,
respectively (Figure 4B), without significantly affecting gacA
expression in the 1rpoN and 1rpoS mutants. In contrast to the
modest change of gacA expression observed in LB medium, the
1rpoN, 1rpoS, and 1rpoN1rpoS mutants demonstrated a 6.2-,
7.6-, and 14.5-fold lower expression of rsmA, respectively, relative
to wild-type PAO1 (Figure 4C). The addition of tobramycin to
stationary phase cells in LB medium decreased the rsmA levels
in wild-type PAO1 and the 1rpoN1rpoS mutant by 2.6- and
1.8-fold, respectively, without significantly altering the levels of
rsmA in the 1rpoN and 1rpoS mutants (Figure 4C). In AB
medium, wild-type PAO1 and the 1rpoN and 1rpoN1rpoS
mutants displayed no difference in rsmA expression, and
tobramycin addition negatively affected the expression of rsmA
in these strains (Figure 4D). The 1rpoS mutant demonstrated
significantly lower expression of rsmA in comparison to wild-
type PAO1, and the addition of tobramycin did not alter rsmA
expression in the 1rpoSmutant (Figure 4D).
To address the correlation between the metabolic status of the
cells produced by different growth media on an increase in the
levels of ppGpp, a regulator of the stringent response synthesized
through the activity of RelA (Cashel et al., 1996), we examined
the transcriptional levels of relA in wild-type PAO1 and the
mutant strains. In LB medium, the highest effect was observed in
the 1rpoN mutant, which produced a modest 1.45-fold increase
in relA expression relative to wild-type PAO1 (Figure 4E). The
addition of tobramycin led to a significant 2.2-fold decrease
in relA level in the 1rpoN mutant and a 1.8-fold increase
in relA level in the 1rpoN1rpoS mutant while the 1rpoS
mutant demonstrated reduced relA expression relative to wild-
type PAO1 (Figure 4E). The levels of relA expression remained
similar in all strains in AB medium; however, the addition of
tobramycin stimulated a 2-fold increase in relA expression in
the 1rpoN1rpoS mutant, with a similar upregulation observed
in wild-type PAO1 (Figure 4F). The level of relA expression
in the 1rpoN and 1rpoS mutants remained unchanged in AB
medium irrespective of tobramycin addition, however, the1rpoS
mutant demonstrated significantly lower expression of relA in
comparison to wild-type PAO1 (Figure 4F).
The RpoS-dependent role in coordinating stationary phase
survival (Suh et al., 1999) and the positive effect of relA-mediated
ppGpp production on rpoS expression (Battesti et al., 2011)
prompted us to investigate the transcriptional levels of rpoS.
In LB medium, the expression of rpoS was increased in the
1rpoN mutant relative to wild-type PAO1 (Figure 4G). The
addition of tobramycin to stationary phase1rpoNmutant cells in
LB provoked a downregulation of rpoS expression (Figure 4G).
In AB medium, no significant difference in rpoS expression
was observed in the 1rpoN mutant relative to wild-type PAO1
(Figure 4H).
To obtain insight into the underlying molecular mechanism
of tobramycin tolerance of the logarithmic phase cells grown in
the nutrient-rich LB medium, we performed a transcriptional
analysis of gacA, rsmA, rpoS, and relA expression in wild-type
PAO1 and the 1rpoN, 1rpoS, 1rpoN1rpoS, and 1rpoN/rpoN+
mutants at time point t = 0 h and time point t = 3 h
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FIGURE 4 | Expression of gacA, rsmA, relA, and rpoS genes in stationary phase wild-type PAO1 and the 1rpoN, 1rpoS, 1rpoN1rpoS, and
1rpoN/rpoN+ mutants grown in the LB medium (A,C,E,G) and in AB minimal medium (B,D,F,H). The gacA, rsmA, relA, and rpoS transcript levels were
measured by qRT-PCR, were normalized to omlA expression, and the levels are expressed relative to the wild-type PAO1 at time = 0 h. The time points at which the
cells were sampled for transcriptional analysis were t = 0 h and t = 24 h after the addition of 32 µg/ml tobramycin, as indicated. All results are the average of at least
three independent experiments, and the error bars represent SDs. P ≤ 0.05 (*), ≤0.01 (**).
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after tobramycin addition. The transcriptional analysis revealed
significantly lower expression of gacA in the 1rpoS mutant
relative to wild-type PAO1 (Figure 5A). Whereas tobramycin
addition led to a decrease in gacA levels in wild-type PAO1 and
the1rpoN mutant, it produced a significant effect in the opposite
direction in the 1rpoS and 1rpoN1rpoS mutants by increasing
the transcription of gacA by 2.8- and 2.1-fold, respectively
(Figure 5A). Based on rsmA transcriptional expression, no
significant difference was observed between wild-type PAO1 and
the 1rpoN, 1rpoS, and 1rpoN1rpoS mutants and the addition
of tobramycin led to a significant increase in rsmA levels by 3.8-
, 5.3-, and 4.3-fold in wild-type PAO1, the 1rpoN mutant, and
the 1rpoS mutant, respectively (Figure 5B). Deletion of rpoN
did not affect rpoS transcriptional levels in the logarithmic phase
cells; however, tobramycin induced a decrease in rpoS levels in
the 1rpoN mutant (Figure 5C).
Wild-type PAO1 and the 1rpoN, 1rpoS, and 1rpoN1rpoS
mutants demonstrated no significant differences in relA
expression (Figure 5D). However, a prominent downregulation
of relA expression by tobramycin in wild-type PAO1 and
the 1rpoN and 1rpoS mutants by 3.6-, 3.8-, and 1.9- fold,
respectively, was evident (Figure 5D). Conversely, in the
1rpoN1rpoS mutant, the levels of relA remained unaltered
upon tobramycin addition (Figure 5D). Complementation of
the 1rpoN mutant with the wild-type rpoN gene demonstrated
that the changes in the expression of gacA, rsmA, relA, and rpoS
genes could be attributed to the loss of RpoN.
Taken together, the transcriptional analysis results led to
several important conclusions: (i) depending on the nutritional
status of the cells, RpoN responds to tobramycin by modulating
the expression of gacA, rsmA, relA, and rpoS; (ii) depending on
the growth phase and nutritional status of the cells, the expression
of rsmA and gacA is regulated through a RpoS-dependent
pathway; (iii) RpoS modulates relA expression in response to
tobramycin; (iv) the loss of both RpoN and RpoS in logarithmic
phase cells results in relA expression that is unresponsive to
tobramycin, leading to the increased survival; and (v) RpoN likely
affects the survival to tobramycin challenge in the logarithmic
phase through a pathway integrally linked to RpoS.
DISCUSSION
The ability of P. aeruginosa to promptly acquire the response
to antibiotic-induced stress conditions through its complex
regulatory networks is crucial for survival (Morita et al., 2014).
The sigma factor RpoN is involved in nitrogen metabolism,
carbon assimilation, nutrient transport, motility, mucoidy, and
QS regulation (Potvin et al., 2008). Taking into account that the
role of RpoN in the tobramycin stress response is defined by its
close regulatory association with the stringent response network
FIGURE 5 | Expression of gacA (A) , rsmA (B), rpoS (C), and relA (D) in logarithmic phase wild-type PAO1 and the 1rpoN, 1rpoS, 1rpoN1rpoS, and
1rpoN/rpoN+ mutants grown in the LB medium in the presence of 32 µg/ml tobramycin. The transcript levels were measured by qRT-PCR, were normalized to omlA
expression, and are expressed relative to wild-type PAO1 at time = 0 h. The time points at which the cells were sampled for transcriptional analysis were t = 0 h and
t = 3 h after the addition of tobramycin, as indicated. All results are the average of at least three independent experiments, and the error bars represent SDs. P ≤ 0.05
(*), ≤0.01 (**).
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and by its importance in the regulation of genes involved in the
translation apparatus (Brown et al., 2014; Schulz et al., 2015), we
were interested in furthering our understanding of the network
linking RpoN with the tobramycin stress response. In addition,
given that RpoN is involved in the regulation of RpoS (Kayama
et al., 2009; Viducic et al., 2016), we aimed to address whether
the observed interaction with RpoS is involved in the tobramycin
stress response. Due to the significant impact of the metabolic
status of the cells on the response to antimicrobial agents (Poole,
2012), our interest was further directed toward investigating how
metabolic alterations affect tobramycin stress-response.
In this study, we have demonstrated that RpoN promotes
P. aeruginosa survival in the presence of tobramycin. The loss
of RpoN in the logarithmic growth phase could be alleviated
through the inactivation of RpoS, highlighting the importance
of interaction between RpoN and RpoS in the tobramycin stress
response in the logarithmic growth phase. These observations
prompted us to examine the network affected as a consequence
of the rpoN and rpoS inactivation and determine how it
correlates with the response to tobramycin. On the basis of
our observations, we propose a model of an RpoN-dependent
network for interaction with tobramycin (Figure 6). Taking
into account that tobramycin requires translation to exert
its bactericidal activity, we were interested in examining the
regulators that are closely associated with translation. Our results
demonstrated that during the stationary growth phase under
nutrient replete conditions, RpoN exerts substantial positive
control over RsmA. As RsmA is a posttranscriptional regulatory
protein, which binds to the 5′-UTR of a mRNA close to the
Shine–Dalgarno region and directly blocks the translation of
the mRNA (Brencic et al., 2009), this observation suggested
that RpoN integrates the RsmA regulatory pathway to modulate
tobramycin-mediated changes in cell metabolism. While RpoN
does not alter the expression of gacA during growth under
nutrient replete conditions, the inability of the 1rpoN mutant to
increase gacA expression in response to tobramycin (the 1rpoN
mutant demonstrates a 2.4-fold decrease in gacA expression)
suggested that RpoN requires GacA to adequately respond to
tobramycin.
Furthermore, our transcriptional analysis demonstrated that
the loss of RpoS in the 1rpoN mutant background provoked
significant alteration in the expression of gacA in the absence or
presence of tobramycin in stationary phase cells. The support for
RpoS-dependent expression of gacA comes from the observations
that under nutrient-limited conditions and during logarithmic
growth phase in LB medium, RpoS affects the expression of
FIGURE 6 | Proposed model for the involvement of RpoN in the regulation of tobramycin tolerance in the stationary growth (A) and logarithmic phase
growth (B) in nutrient-rich medium. (A) RpoN stimulates the expression of the genes involved in the translation apparatus and positively affects the synthesis of
ribosome components. Upon exposure to tobramycin, RpoN counteracts the negative effects of tobramycin on translation by increasing the expression of relA, which
in turn produces the effector of the stringent response, ppGpp. ppGpp promotes survival in the presence of tobramycin by inducing translational inactivity and
affecting the growth rate. The translational inactivity produced by ppGpp blocks tobramycin from exerting its effect on the ribosome and consequently leads to
tobramycin tolerance. In addition, RpoN positively affects the expression of rpoS in the presence of tobramycin and employs RsmA to overcome the effect of
tobramycin, likely by increasing the mRNA stability of a gene potentially involved in tobramycin tolerance. RpoN increases the expression of gacA in response to
tobramycin, which probably occurs through a ppGpp-dependent pathway. (B) During the logarithmic phase of growth, RpoN employs the RpoS-dependent pathway,
which in turn activates additional stress-response genes promoting the survival to tobramycin. RpoN profoundly downregulates the expression of rsmA in response to
tobramycin. Furthermore, RpoS negatively affects the expression of gacA in the presence of tobramycin. The mutant deficient in rpoN and rpoS demonstrates (i) the
loss of tobramycin-mediated inhibition of relA expression, (ii) a consequent increase in ppGpp production, and (iii) suggests ppGpp-dependent upregulation of gacA,
which together lead to tobramycin tolerance. The detailed regulation network is described in the Discussion. OM, outer membrane; PS, periplasmic space; IM, inner
membrane; TOB, tobramycin; → represents positive control; ⊥ represents negative control.
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gacA. Furthermore, our results demonstrated pronounced RpoS-
mediated control of rsmA expression. Given our results, and
the previously published observations on the regulatory link
between RsmA and RpoS in P. aeruginosa showing that RpoS
positively affects the expression of rsmA (Schulz et al., 2015;
Stacey and Pritchett, 2016), our observations further demonstrate
that RpoN likely modulates the expression of rsmA through an
RpoS-dependent regulatory network. In addition, RpoN might
employ RsmA to increase mRNA stability of the gene targeted
by tobramycin due to the fact that RsmA may also contribute to
positive regulation of mRNA (Romeo et al., 2013; Yakhnin et al.,
2013). Phenotypic association of the RsmA- and RpoN-network
in biofilm formation, interaction with antimicrobial agents, and
regulation of T6SS (Burrowes et al., 2006; Mulcahy et al., 2008;
Brencic and Lory, 2009; Sana et al., 2013) further strengthens the
complex relationship between these regulators.
One possibility for the importance of RpoS in the RpoN
network is that RpoN affects tobramycin tolerance through
modulation of rpoS expression. This postulation is in accordance
with previous observations suggesting that RpoS is an important
target for interaction with aminoglycosides (Baharoglu et al.,
2013; Wang et al., 2014). Our transcriptional results suggested
that RpoN employs RpoS to alleviate the effects of tobramycin
in the stationary and logarithmic growth phases. RpoS has a
dominant effect on gene expression in the stationary growth
phase, controlling approximately 14% of the P. aeruginosa
genome and exerting a positive regulation over genes involved
in the regulation of chemotaxis, two-component regulatory
systems, QS, alginate synthesis, and the RpoS-activated katA
and lecA genes (Schuster et al., 2004). Considering the close
regulatory association of RpoN with the sensor kinase KinB
in the regulation of the genes involved in alginate synthesis,
QS, virulence factor production, and carbohydrate metabolism
(Damron et al., 2012), there is a substantial overlap between
RpoN- and RpoS-dependent gene expression. This overlap
underscores the importance of the interaction between RpoN
and RpoS in response to diverse environmental stimuli, including
antibiotic stress.
In addition, our killing assays demonstrated that RpoS
was important in mediating the tobramycin response in the
logarithmic cells grown in the minimal medium, while no
significant role for RpoS was observed in the stationary phase or
logarithmic phase cells grown in LB medium. In contrast with
our observations, the importance of RpoS in the response to
aminoglycoside-induced stress has been demonstrated in E. coli
(Wang et al., 2014). Furthermore, RpoS protects E. coli and
V. cholerae from subinhibitory concentrations of tobramycin-
induced SOS (Baharoglu et al., 2013). In our studies the cells were
treated with a high concentration of antibiotic, corresponding
to 32 × MIC, suggesting that the RpoS-dependent response
can be distinguished only when using lower concentration of
tobramycin. In addition to antibiotic concentration, the response
to antibiotics may be affected by the growth conditions, growth
medium, or the strains used in the study. Furthermore, there
appears to be a considerable difference in the expression of genes
involved in cell division, cell wall synthesis, as well as adaptation
and protection, between the 1rpoS mutant of P. aeruginosa and
E. coli (Schuster et al., 2004). As proposed by Schuster et al.,
in P. aeruginosa, these genes comprise a minor fraction of the
genes induced by RpoS, and because they play a vital role in
the response to a variety of stresses, this observation may aid
in explaining the less sensitive antibiotic stress phenotype of the
1rpoS P. aeruginosamutant relative to the E. coli 1rpoSmutant.
We anticipated that another target for interaction with RpoN
might be the relA gene, which is responsible for production of the
stringent response effector molecule, ppGpp, and is essential for
survival of the cells (Cashel et al., 1996). The nutrient status of the
cells is an important signal in modulating the intracellular levels
of ppGpp by directly activating the expression of relA, and it has
been demonstrated that the nitrogen stress response integrates
ppGpp-mediated changes to adapt to low nitrogen availability
(Brown et al., 2014). The observed increase in relA transcriptional
expression in stationary phase 1rpoN1rpoS mutant cells in
response to tobramycin, irrespective of the nutrient conditions,
underscores the importance of ppGpp in tobramycin tolerance.
In addition, RpoS affects relA expression in response to
tobramycin. Activation of the stringent response results in a
reduction of ribosomes synthesis due to downregulation of
ribosomal RNA (Potrykus and Cashel, 2008). These restrictive
conditions impede the action of tobramycin and allow the cells
deprived of the alternative sigma factors RpoN and RpoS to
antagonize the effect of tobramycin via a mechanism dependent
on the relA gene.
The present study found that there was no influence of relA on
the response to tobramycin in logarithmic phase 1rpoN mutant
cells as determined by transcriptional analysis, but this study did
demonstrate that relA-dependent ppGpp production alleviated
the effect of tobramycin in the 1rpoN1rpoS mutant. Consistent
with this finding, the inability of the 1rpoN mutant to fine tune
the stringent response during tobramycin treatment correlated
with a decrease in survival to tobramycin. The impact of RpoN
on relA expression during the stationary growth phase in the
presence of tobramycin led us to postulate, and further to confirm
through the observations by Schulz et al., that the role of RpoN
in tobramycin tolerance stems from its close association with
the ribosome. The evidence of the complex regulatory network
interconnected with RpoN was demonstrated using ChIP-seq
in combination with a motif scan, in which RpoN was found
to regulate 53 genes involved in translation, post-translational
modification, and degradation (e.g., genes that belong to the rpl,
rps, and rpm ribosomal clusters (Schulz et al., 2015).
These observations and the findings of this study prompted
us to postulate that the prompt response to tobramycin requires
RpoN to enhance the expression of rsmA and maintain stability
of its expression. In this scenario, RpoN acts by employing
RsmA to positively affect the mRNA of the target genes by likely
involvement in ribosome synthesis and by promoting ribosome-
dependent relA expression to mount the stringent response,
which together subsequently affects survival to tobramycin.
While the observations reached in the study by Schulz et al.,
provide an explanation for the tobramycin-sensitive phenotype
of the 1rpoN mutant during the stationary growth phase, in
the logarithmic growth phase, RpoN interacts with RpoS and
with additional stress-response genes to promote translational
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inactivity to overcome the effects of tobramycin. This explanation
is supported by the data showing no difference in relA expression
between the 1rpoN mutant and the wild type. Interestingly, the
1rpoN mutant demonstrated significantly higher expression of
rsmA in the logarithmic phase cells in response to tobramycin,
underscoring the importance of interaction between RpoN and
RsmA in modulating the response to tobramycin. In support
of this observation, Schulz et al. have demonstrated that RpoN
controls a number of non-coding RNAs, suggesting that RpoN
might employ non-coding RNAs to interact with RsmA to
promote the cellular reaction to tobramycin.
It has been demonstrated that ppGpp affects the expression
of csrA, a homolog of RsmA in E. coli, through positive
effects on csrB/C non-coding RNAs, which antagonize CsrA.
Furthermore, CsrA directly controls relA suggesting that CsrA
is engaged in fine-tuning the stringent response (Edwards et al.,
2011). In Pseudomonas fluorescens CHA0, GacA is involved
in the regulation of ppGpp and during nutrient-restricted
conditions ppGpp activates the Gac/Rsm pathway (Takeuchi
et al., 2012). Concordant with these observations, increased relA
levels in logarithmic phase cells of the 1rpoN1rpoS mutant
and consequent ppGpp production, suggest the existence of a
potential ppGpp-dependent upregulation of gacA in the presence
of tobramycin.
RpoN-dependent control of aminoglycoside tolerance has
previously been reported in Pseudomonas fluorescens SBW25
(Jones et al., 2007). Increased susceptibility of the 1rpoN
mutant to tobramycin could be attributed to the alterations in
the expression of RpoN-controlled flagellar genes, which have
recently been implicated in aminoglycoside tolerance (Shan et al.,
2015).
Given the increasing evidence supporting the association of
ppGpp with tolerance to antibiotics in P. aeruginosa (Viducic
et al., 2006; Khakimova et al., 2013), what we can deduce from the
observations of this study is that based on the growth phase and
nutritional status of the cells, RpoN cooperates with the RelA-
dependent ppGpp production pathway through its regulatory
control of the translation apparatus, with RpoS and with the
RsmA-dependent pathway to integrate the network required for
survival in the presence of tobramycin. Future studies will be
required to delineate the RpoN-mediated tobramycin tolerance
pathway in order to advance the understanding of the effects of
RpoN on cellular functions.
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